Nowak P, Rossi M, Kowalski A. "Method for the Synthesis of Acalabrutinib Impurity 29" [P]. European Patent, EP 3434419 A1, 2019-09-01.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 阿可替尼杂质29 in Pharmaceutical Formulations". Phytochemistry, 2019, 653, (10), 4675-4693.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿可替尼杂质29 as an Impurity". J. Nat. Prod., 2020, 142, 7698-7708.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Acalabrutinib Impurity 29 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2017, 645, 9931-9960.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 阿可替尼杂质29 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2017, 1172, (6), 6518-6533.